Profile of Stephanie Kreml
News & Commentary Posts: 7
Stephanie Kreml, M.D., is a Principal at Popper and Company. In her current role, she develops and implements business strategy for start-up companies and new business units in existing companies; consults in areas of clinical need, commercialization, and technology assessment; performs due diligence for investment and acquisition targets in the life science industry; critically evaluates unmet clinical needs and technologies; and provides guidance to accelerate new product development activities.
Articles by Stephanie Kreml
EHRs should be adaptive, so that when something like the Ebola outbreak occurs, the overworked ER doc has help catching the one critical piece of information that wasn't as relevant a year ago.
AMA attempts to address the frustration EHRs create, especially for doctors and other healthcare workers.
The FDA's reluctance to overregulate medical apps opens a pitfall for healthcare organizations that innovate too far ahead of the curve.
Developers struggle to find the line between unregulated health apps and regulated medical apps. Here's some guidance.
Better training and the equivalent of a surgeon's touch are needed to make surgical robots live up to their hype (and potential).
Beyond keeping patients well, today's healthcare providers must keep them happy.
Congress attempts to clarify which health software should be regulated like a medical device with the Sensible Oversight for Technology which Advances Regulatory Efficiency Act.